Edinburgh Research Explorer

Relative adrenal insufficiency in mice deficient in 5α-reductase 1

Research output: Contribution to journalArticlepeer-review

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: This work is licensed under a Creative Commons Attribution 3.0 Unported License

    Final published version, 343 KB, PDF document

http://joe.endocrinology-journals.org/content/222/2/257
Original languageEnglish
Pages (from-to)257-266
Number of pages10
JournalJournal of Endocrinology
Volume222
Issue number2
Early online date1 Aug 2014
DOIs
Publication statusPublished - 1 Aug 2014

Abstract

Patients with critical illness or hepatic failure exhibit impaired cortisol responses to ACTH, a phenomenon known as 'relative adrenal insufficiency'. A putative mechanism is that elevated bile acids inhibit inactivation of cortisol in liver by 5α-reductases type 1 and type 2 and 5β-reductase, resulting in compensatory downregulation of the hypothalamic-pituitary-adrenal axis and adrenocortical atrophy. To test the hypothesis that impaired glucocorticoid clearance can cause relative adrenal insufficiency, we investigated the consequences of 5α-reductase type 1 deficiency in mice. In adrenalectomised male mice with targeted disruption of 5α-reductase type 1, clearance of corticosterone was lower after acute or chronic (eightfold, P<0.05) administration, compared with WT control mice. In intact 5α-reductase-deficient male mice, although resting plasma corticosterone levels were maintained, corticosterone responses were impaired after ACTH administration (26% lower, P<0.05), handling stress (2.5-fold lower, P<0.05) and restraint stress (43% lower, P<0.05) compared with WT mice. mRNA levels of Nr3c1 (glucocorticoid receptor), Crh and Avp in pituitary or hypothalamus were altered, consistent with enhanced negative feedback. These findings confirm that impaired peripheral clearance of glucocorticoids can cause 'relative adrenal insufficiency' in mice, an observation with important implications for patients with critical illness or hepatic failure, and for patients receiving 5α-reductase inhibitors for prostatic disease.

    Research areas

  • glucocorticoids, 5 alpha-reductases, adrenal insufficiency, HPA axis, CORTICOTROPIN-RELEASING HORMONE, 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1, CORTISONE REDUCTASE DEFICIENCY, POLYCYSTIC-OVARY-SYNDROME, HYPOTHALAMIC PARAVENTRICULAR NUCLEUS, MESSENGER-RNA LEVELS, GENE-EXPRESSION, SEPTIC SHOCK, GLUCOCORTICOID METABOLISM, BRAIN 5-ALPHA-REDUCTASE

Download statistics

No data available

ID: 16533474